Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer ...

Jan 27 (Reuters) - Veru (VERU.O), opens new tab said on Monday its experimental drug in combination with Novo Nordisk's (NOVOb.CO), opens new tab weight-loss treatment Wegovy, helped preserve ...

Wegovy added DKK 19.9B in sales in Q4, over a twofold rise from a year ago. Eli Lilly (LLY) is due to report its own Q4 results tomorrow, with a consensus EPS estimate of $5.11 and revenue ...

The company's blockbuster semaglutide drugs, Wegovy for weight loss and Ozempic for diabetes, are key to the company's beat. Combined, they brought in $24.9 billion for the year. That's compared ...

A breakthrough in weight loss medication is on the horizon. While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient ...

MIAMI - Drugs like Ozempic, Wegovy and Mounjaro have transformed the weight loss industry, becoming household names seemingly overnight. Touted as game-changers, these medications not only help ...